Robert M. Patterson - 11 Feb 2022 Form 4 Insider Report for AVIENT CORP (AVNT)

Role: Chairman, President & CEO, Director
Signature: /s/ Lisa K. Kunkle, Power of Attorney For: Robert M. Patterson
Issuer symbol: AVNT
Transactions as of: 11 Feb 2022
Transactions value $: -$1,226,354
Form type: 4
Filing time: 15 Feb 2022, 16:20:35
Previous filing: 30 Aug 2021
Next filing: 03 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AVNT	Common Stock	Options Exercise		+49K	+9.8%		548K	11 Feb 2022	Direct	F1, F2
transaction	AVNT	Common Stock	Tax liability	-$1.23M	-23.3K	-4.25%	$52.64	525K	11 Feb 2022	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AVNT	Restricted Stock Units	Options Exercise		-49K	-50%		49K	11 Feb 2022	Common Stock	49K		Direct	F1
transaction	AVNT	Restricted Stock Units	Award	$0	+38.2K		$0.00	38.2K	14 Feb 2022	Common Stock	38.2K		Direct	F1
transaction	AVNT	Stock Appreciation Rights	Award	$0	+135K		$0.00	135K	14 Feb 2022	Common Stock	135K	$52.64	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Avient common stock.
F2	Includes dividend equivalents earned with respect to the vested restricted stock units.
F3	Represents shares of Avient common stock that were withheld solely to satisfy the tax withholding obligation applicable to the vesting of restricted stock units on February 11, 2022.
F4	SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $52.64 per share and no more than one-third of the grant can vest per year during the first three years.